# CION Investment Corp: overview

CION · NYSE · CIK 1534254 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cion.md) · [Financials](/companies/cion/financials.md) · [Filings](/companies/cion/filings.md) · [Insiders](/companies/cion/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $ | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cion/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Bulldog Investors, LLP](/funds/1504304.md) | 2026-06-30 | $9.6m | 1,538,071 |  | Unchanged |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $8.5m | 1,368,725 |  | Added +751,300 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $7.9m | 1,266,950 |  | Added +114,000 |
| [VAN ECK ASSOCIATES CORP](/funds/869178.md) | 2026-06-30 | $7.7m | 1,236,397 |  | Added +268,242 |
| [LPL Financial LLC](/funds/1403438.md) | 2026-06-30 | $6.3m | 1,019,029 |  | Added +29,876 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $5.7m | 915,653 |  | Added +232,651 |
| [Callodine Capital Management, LP](/funds/1741675.md) | 2026-06-30 | $4.2m | 674,138 |  | Added +61,750 |
| [Berger Financial Group, Inc](/funds/1826136.md) | 2026-06-30 | $2.5m | 404,493 |  | Reduced −2,406 |
| [Arkadios Wealth Advisors](/funds/1800798.md) | 2026-06-30 | $2.0m | 322,360 |  | Reduced −13,058 |
| [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $1.9m | 312,707 |  | Reduced −35,933 |

## Recent filings

[All 887 filings](/companies/cion/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 14:40 ET | [8-K](/filings/0001104659-26-118023.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-118023 |
| 2026-10-01 | 12:30 ET | [8-K](/filings/0001104659-26-112595.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-112595 |
| 2026-09-29 | 20:45 ET | [8-K](/filings/0001104659-26-111961.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-111961 |
| 2026-09-17 | 21:00 ET | [8-K](/filings/0001104659-26-108606.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-108606 |
| 2026-08-06 | 12:30 ET | [8-K](/filings/0001104659-26-091692.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-091692 |
| 2026-08-06 | 23:35 ET | [10-Q](/filings/0001534254-26-000010.md) | Quarterly report, period 2026-06-30 | 0001534254-26-000010 |
| 2026-07-16 | 20:08 ET | [8-K](/filings/0001104659-26-084247.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-084247 |
| 2026-07-01 | 12:30 ET | [8-K](/filings/0001104659-26-079609.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-079609 |
| 2026-06-26 | 14:32 ET | [8-K](/filings/0001104659-26-078073.md) | 5.07 Shareholder vote results | 0001104659-26-078073 |
| 2026-05-07 | 12:30 ET | [8-K](/filings/0001104659-26-056729.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-056729 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001534254-26-000003.md), filed Mar 12, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1534254
- Tickers: CION, CICC, CICB
- Exchange: NYSE
- SIC code: not reported
- State of incorporation: MD
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.
